Resumption of Enteral Feeding After Bowel Anastomosis

March 25, 2025 updated by: Dr Saeed Sarwar, Khyber Teaching Hospital

Comparison of Early Versus Late Resumption of Enteral Feeding After Small Bowel Anastomosis.

Resumption of oral feeding after small intestine surgery is a matter of controversy .Some surgeons advocate early resumption while others don't.early feeding is initiated as soon as the patient recovers from effects of anaesthesia, while late resumption is started after 24-48 hours after surgery.Recent studies and guidelines suggest early feeding. The aim of this study is to compare the early and late resumption of oral feeding.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

204

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Pakistan
    • KPK
      • Peshawar, KPK, Pakistan, 25000
        • Recruiting
        • Khyber Teaching Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • All patients undergoing small bowel anastomosis for any indication in elective setting
  • Patients of age between 15 to 65 years.
  • All genders

Exclusion Criteria:

  • Patient using glucocorticoids or other immunosuppressive drugs
  • non conseting individuals
  • Patient having history of gastrectomy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Early group
Early group includes patients in whom enteral feeding is resumed within 24 hours once fully conscious from effects of anesthesia
Other: resumption of enteral feeding within 24 hours of surgery
Patients will be subjected to resumption of enteral feeding within 24 hours of surgery
Other: resumption of enteral feeding after 24-48 hours
Patients will be subjected to late resumption of enteral feeding after 24 to 48 hours of surgery
Experimental: Late group
Late group includes patients in whom enteral feeding is started 24-48 hours after recovery from anesthesia
Other: resumption of enteral feeding within 24 hours of surgery
Patients will be subjected to resumption of enteral feeding within 24 hours of surgery
Other: resumption of enteral feeding after 24-48 hours
Patients will be subjected to late resumption of enteral feeding after 24 to 48 hours of surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to passage of stool/flatus
Time Frame: Upto 2 weeks from surgery .From the time of surgery to passage of stool or flatus or death due to any cause, whichever comes first.
Time to passage of stool or flatus after surgery ,as reported by the patient or noticed by nurse.Time will be measured in day(s).
Upto 2 weeks from surgery .From the time of surgery to passage of stool or flatus or death due to any cause, whichever comes first.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital stay
Time Frame: Upto 50 weeks postoperatively ,From surgery to discharge or death , whichever comes first.
Number of days spent at hospital from time of surgery till discharge from hospital
Upto 50 weeks postoperatively ,From surgery to discharge or death , whichever comes first.
Vomiting
Time Frame: Upto 50 weeks postoperatively ,From surgery to discharge or death , whichever comes first.
if vomiting occured or not during time of study.
Upto 50 weeks postoperatively ,From surgery to discharge or death , whichever comes first.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Khyber Teaching Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2024

Primary Completion (Estimated)

December 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

March 19, 2025

First Submitted That Met QC Criteria

March 25, 2025

First Posted (Actual)

April 2, 2025

Study Record Updates

Last Update Posted (Actual)

April 2, 2025

Last Update Submitted That Met QC Criteria

March 25, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 806/DME/KMC

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data about patients will not be shared due to confidentiality issues.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anastomotic Leak

Clinical Trials on resumption of enteral feeding within 24 hours of surgery

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe